Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PRP vs Corticosteroid for Knee OA
NCT06703970Completed
- Sponsor
- LifeBridge Health
- Start
- Feb 2022
- Primary completion
- Jul 2024
- Modality
- Adoptive Cell Transfer
- Countries
- 1
01
Overview
Randomised, single-blind trial of autologous platelet-rich plasma in knee osteoarthritis (OA) (2 arms), sponsored by LifeBridge Health. Primary endpoint: Pain score Visual Analog Scale at 3 months. Started Feb 2022; status: completed.
02
Drugs
autologous platelet-rich plasma
03
Conditions
knee osteoarthritis (OA)
Beyond the preview
Go deeper on NCT06703970.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06703970.